glp-1 and crohn's Frontiers The Potential for GLP-1s in

Any study that appeared to meet the predefined eligibility criteriaoutlined in Table 1 and focused on the role of GLP-1 agonists in body weight regulation and neuroprotection, was selected for further evaluation and full-text review

This can lead to fatty liver disease , both in people who abuse alcohol and in people who have fatty liver due to poor diet and sedentary lifestyle

[6] These analyses are useful, but they are the weakest tier for a two-drug verdict: indirect comparisons inherit every difference between the underlying trials and cannot substitute for a randomised head-to-head

Bottom line The current research is limited and cannot prove that artificial sweeteners cause cancer